Superion® Interspinous Spacer System
The Superion Interspinous Spacer (ISS) is a motion-preserving, indirect decompression spinal implant system for the treatment
of moderate lumbar spinal stenosis. Superion is the most advanced, least invasive and currently the only ISS available or in development.
Key Features of the Superion System Include:
• One piece, expandable implant
• Minimally invasive midline approach
• Motion preserving
• Tissue sparing and fully reversible
The Superion ISS system is designed to deliver the implant through a single small incision in the patient's back, utilizing VertiFlex’ proprietary interspinous access platform. The procedure can be performed under local anesthesia on an outpatient basis and closed with a single suture. Once in place, it may reduce pressure on the nerves that cause pain and allow the return to a more active lifestyle.
Superion has been CE marked since 2007 and following a clinical study of 470 patients, was PMA approved by the FDA on May 20, 2015,
clearing the way for U.S. commercialization. Superion has been implanted in over 2000 patients worldwide. To date, VertiFlex has
compiled the largest, most rigorous, body of device clinical evidence, related to lumbar spinal stenosis.
Superion Surgical Technique